Suppr超能文献

根据2016年世界卫生组织肾肿瘤分类诊断的肾细胞癌亚型的预后因素:一项涉及928例患者的研究

Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.

作者信息

Kuthi Levente, Jenei Alex, Hajdu Adrienn, Németh István, Varga Zoltán, Bajory Zoltán, Pajor László, Iványi Béla

机构信息

Department of Pathology, University of Szeged, Állomás Street 1, Szeged, H-6725, Hungary.

Department of Dermatology and Allergology, University of Szeged, Korányi Alley 6, Szeged, H-6720, Hungary.

出版信息

Pathol Oncol Res. 2017 Jul;23(3):689-698. doi: 10.1007/s12253-016-0179-x. Epub 2016 Dec 28.

Abstract

The morphotype and grade of renal cell carcinoma (RCC) in 928 nephrectomies were reclassified according to the 2016 WHO classification in order to analyze the distribution and outcomes of RCC subtypes in Hungary, to assess whether microscopic tumor necrosis is an independent prognostic factor in clear cell RCC, and to study whether a two-tiered grading (low/high) for clear cell and papillary RCC provides similar prognostic information to that of the four-tiered ISUP grading system. 83.4% of the cohort were clear cell, 6.9% papillary, 4.5% chromophobe, 2.3% unclassified, 1.1% Xp11 translocation, 1.1% clear cell papillary, 0.3% collecting duct and 0.1% mucinous tubular and spindle cell RCCs. RCC occurred in 16 patients with end-stage kidney disease and none of them displayed features of acquired cystic kidney disease-associated RCC. The 5-year survival rates were as follows: chromophobe 100%, clear cell papillary 100%, clear cell low-grade 96%, papillary type 1 92%, clear cell high-grade 63%, papillary type 2 65%, unclassified 46%, Xp11 translocation 20%, and collecting duct 0%. The 5-year survival rates in low-grade and high-grade papillary RCC were 95% and 59%, respectively. In clear cell RCC, only the grade, the stage and the positive surgical margin proved to be independent prognostic factors statistically. Overall, papillary RCC occurred relatively infrequently; microscopic tumor necrosis in clear cell RCC did not predict the outcome independently of the tumor grading; and the assignment of clear cell and papillary RCCs into low-grade or high-grade tumors was in terms of survival no worse than the ISUP grading.

摘要

对928例肾切除术患者的肾细胞癌(RCC)的形态类型和分级按照2016年世界卫生组织分类标准重新分类,以分析匈牙利RCC亚型的分布和预后,评估微小肿瘤坏死是否为透明细胞RCC的独立预后因素,并研究透明细胞和乳头状RCC的两级分级(低/高)是否能提供与国际泌尿病理学会(ISUP)的四级分级系统相似的预后信息。该队列中83.4%为透明细胞型,6.9%为乳头状,4.5%为嫌色细胞型,2.3%为未分类型,1.1%为Xp11易位型,1.1%为透明细胞乳头状型,0.3%为集合管型,0.1%为黏液性管状和梭形细胞RCC。RCC发生于16例终末期肾病患者,其中无一例表现出获得性囊性肾病相关性RCC的特征。5年生存率如下:嫌色细胞型100%,透明细胞乳头状型100%,透明细胞低级别96%,乳头状1型92%,透明细胞高级别63%,乳头状2型65%,未分类型46%,Xp11易位型20%,集合管型0%。低级别和高级别乳头状RCC的5年生存率分别为95%和59%。在透明细胞RCC中,只有分级、分期和手术切缘阳性在统计学上被证明是独立的预后因素。总体而言,乳头状RCC相对少见;透明细胞RCC中的微小肿瘤坏死不能独立于肿瘤分级预测预后;将透明细胞和乳头状RCC分为低级别或高级别肿瘤,就生存率而言并不比ISUP分级差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验